Clinicians must use caution in adopting newly revised national guidelines for treating elevated cholesterol, concludes a new study from the University of Maryland Pharmaceutical Health Services Research Department.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Study cautions against overtreatment when adopting new NCEP III guidelines

Newsletter